查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493186

细胞和基因治疗生物分析测试服务的市场规模、份额和趋势分析报告：按测试类型、按产品类型、按开发阶段、按适应症、按地区和细分市场预测，2024-2030年

Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test Type, By Product Type, By Stage Of Development By Product Type, By Indication, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 261 Pages | 商品交期: 2-10个工作天内

价格

细胞和基因治疗生物分析测试服务市场的成长和趋势：

Grand View Research, Inc.最新报告预测，到2030年，全球细胞和基因治疗生物分析测试服务市场规模将达到8.287亿美元，2024年至2030年复合年增长率为7.3%。

与细胞和基因治疗相关的研发活动的增加、公共机构对细胞和基因治疗研究的投资增加以及基因和细胞治疗在罕见疾病治疗方面的巨大潜力将是推动市场成长的主要因素。

细胞和基因疗法广泛应用于治疗癌症、自体免疫疾病和罕见疾病。这些治疗方法已被证明可以显着改善患者的临床状况，这就是为什么有大量的细胞和基因疗法候选药物正在研发中。例如，根据美国细胞与基因治疗学会的数据，截至 2023 年 1 月，有超过 2,053 种基因治疗药物和 827 种非基因改造细胞治疗药物正在研发中。大量正在研发的细胞和基因治疗候选药物正在推动对生物分析测试服务的需求。

公共机构和私人公司正在积极投资细胞和基因疗法的研究。例如，2023年4月，加州再生医学研究所投资8,900万美元用于干细胞和基因治疗研究。这笔资金旨在开发针对持续性角膜上皮缺陷的治疗方法。未来类似的资金筹措预计将增加预测期内对生物分析测试服务的需求。

COVID-19 大流行对细胞和基因治疗生物分析测试服务市场产生了负面影响。在这次大流行期间，大多数基于细胞和基因疗法的临床测试都被推迟。然而，在后COVID-19时代，情况正在发生变化，许多测试已经恢復。预计这将支持 COVID-19 后时期的市场成长。

细胞/基因治疗生物分析测试服务市场报告亮点

  • 按测试类型划分，生物有效性和生物等效性测试领域占最大销售份额，2023年约为35.4%。生物有效性和生物等效性测试主要集中于细胞治疗、基因治疗等医药和生物技术产品的研发。在细胞和基因治疗中，生物有效性是指施用的治疗剂量到达体循环的速率。
  • 按产品类型划分，细胞疗法占据最大销售份额，2023年为42.1%。细胞疗法在治疗自体免疫疾病和癌症方面具有巨大潜力。这导致了细胞治疗临床研究的改进以及对细胞治疗生物分析服务的需求增加。
  • 根据按产品类型分類的部署阶段，2023 年非临床细分市场将占 66.2% 的份额。非临床生物分析测试对于获得 IND核准至关重要。对研究人员将治疗方法转移到临床阶段的高需求正在支持该领域的市场成长。
  • 根据统计，2023年肿瘤领域的销售额占比最大，为49.0%。基因和细胞疗法有效治疗癌细胞的巨大潜力是该领域市场成长的主要原因。
  • 预计亚太地区在预测期内复合年增长率最高，达 7.7%。公共部门资助基于细胞和基因治疗的研究以及生物分析服务外包的低成本正在支持该地区的市场成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 细胞/基因治疗生物分析测试服务市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 细胞/基因治疗生物分析测试服务市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章细胞/基因治疗生物分析测试服务市场：测试类型的估计和趋势分析

  • 2023年及2030年测试类型市场占有率
  • 细分仪表板
  • 全球血液检测市场：按测试类型分類的前景
  • 2018-2030年市场规模/预测与趋势分析

第五章 细胞/基因治疗生物分析检测服务市场：产品类型估算及趋势分析

  • 2023 年和 2030 年按产品类型市场占有率
  • 细分仪表板
  • 全球细胞和基因治疗生物分析测试服务市场：按产品类型分類的展望
  • 2018-2030年市场规模/预测与趋势分析

第六章 细胞/基因治疗生物分析测试服务市场：依产品类型分類的发展阶段估算及趋势分析

  • 2023年及2030年按产品类型分類的开发阶段市场占有率
  • 细分仪表板
  • 全球细胞和基因治疗生物分析测试服务市场：按产品类型分類的发展阶段展望
  • 2018-2030年市场规模/预测与趋势分析

第七章 细胞/基因治疗生物分析检测服务市场：适应症估算与趋势分析

  • 2023 年及 2030 年按适应症分類的开发阶段市场占有率
  • 细分仪表板
  • 全球细胞和基因治疗生物分析测试服务市场：按适应症分類的发展阶段展望
  • 2018-2030年市场规模/预测与趋势分析

第八章细胞/基因治疗生物分析测试服务市场：区域估计/趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司/竞争对手分类
  • 供应商情况
  • 市场参与企业分类
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • BioAgilytix Labs
    • KCAS Bioanalytical Services
    • IQVIA, Inc.
    • Laboratory Corporation of America Holdings
    • Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
    • Prolytix
    • Pharmaron
    • Charles River Laboratories
    • Syneos Health
    • SGS SA
    • Intertek Group Plc
Product Code: GVR-4-68040-078-3

Cell & Gene Therapy Bioanalytical Testing Services Market Growth & Trends:

The global cell & gene therapy bioanalytical testing services market size is expected to reach USD 828.7 million by 2030, growing at a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing R&D activities related to cell and gene therapy, growth in investments by public organizations for cell and gene therapy research and high potential of gene and cell therapy in treating rare diseases are the key factors driving the growth of the market.

Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.

Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.

The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.

Cell & Gene Therapy Bioanalytical Testing Services Market Report Highlights:

  • Based on test type, the bioavailability & bioequivalence studies segment accounted for the largest revenue share of around 35.4% in 2023. Bioavailability & bioequivalence studies primarily focus on the R&D of pharmaceutical & biotechnological products such as cell and gene therapies. In cell & gene therapies, bioavailability refers to the proportion of the administered dose of a therapeutic agent that reaches the systemic circulation.
  • Based on product type, cell therapy accounted for the largest revenue share of 42.1% in 2023. Cell therapies have great potential in treating autoimmune diseases, cancers, and other conditions. This is improving the clinical research in cell therapy, thus boosting the demand for bioanalytical services for cell therapy.
  • Based on the stage of development by product type, the non-clinical segment held a share of 66.2% in 2023. Bioanalytical testing for non-clinical stage is essential for obtaining IND approval. The high demand among researchers for transitioning the therapy into the clinical stage is supporting the market growth of the segment.
  • Based on indication, the oncology segment held the maximum revenue share of 49.0% in 2023. The high potential of gene and cell therapy to treat cancer cells effectively is the prime reason for the segment market growth.
  • Asia Pacific is anticipated to witness the highest CAGR of 7.7% during the forecast time frame. Funding for cell and gene therapy-based research by public organizations and the low cost associated with outsourcing bioanalytical services in the region is supporting the segment market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test Type
    • 1.2.2. Product Type
    • 1.2.3. Stage of Development by Product Type
    • 1.2.4. Indication
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type
    • 2.2.2. Product Type
    • 2.2.3. Stage of Development by Product Type
    • 2.2.4. Indication
    • 2.2.5. Regional scope
  • 2.3. Competitive Insights

Chapter 3. Cell & Gene Therapy Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Significant Number Of Cell & Gene Therapy Drug Candidates Under Clinical Trials
      • 3.2.1.2. High Public And Private Investments Across Research And Development Of Novel Cell & Gene Products To Augment Market Growth
      • 3.2.1.3. High Focus Of Biopharmaceutical Companies To Reduce Operational Costs Promoting The Demand For Outsourcing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability Of Alternative Treatment Options At Lower Cost
      • 3.2.2.2. Quality Issues Associated With Outsourcing
  • 3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis

Chapter 4. Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 4.1. Test Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Hematology Testing Market by Test Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Bioavailability & Bioequivalence Studies
      • 4.4.1.1. Bioavailability & Bioequivalence Market, 2018 to 2030 (USD Million)
    • 4.4.2. Pharmacokinetics
      • 4.4.2.1. Pharmacokinetics Market, 2018 to 2030 (USD Million)
    • 4.4.3. Pharmacodynamics
      • 4.4.3.1. Pharmacodynamics Market, 2018 to 2030 (USD Million)
    • 4.4.4. Other Test Types
      • 4.4.4.1. Other Test Types Market, 2018 to 2030 (USD Million)

Chapter 5. Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Estimates & Trend Analysis

  • 5.1. Product type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market by Product Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Gene Therapy
      • 5.4.1.1. Gene Therapy Market, 2018 to 2030 (USD Million)
      • 5.4.1.2. Ex-vivo
      • 5.4.1.3. Ex-vivo Market, 2018 to 2030 (USD Million)
      • 5.4.1.4. In-vivo
      • 5.4.1.5. In-vivo Market, 2018 to 2030 (USD Million)
    • 5.4.2. Gene-Modified Cell Therapy
      • 5.4.2.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
      • 5.4.2.2. CAR T-cell therapies
      • 5.4.2.3. CAR T-Cell Therapies Market, 2018 to 2030 (USD Million)
      • 5.4.2.4. CAR-NK cell therapy
      • 5.4.2.5. CAR-NK Cell Therapy Market, 2018 to 2030 (USD Million)
      • 5.4.2.6. TCR-T cell therapy
      • 5.4.2.7. TCR-T Cell Therapy Market, 2018 to 2030 (USD Million)
      • 5.4.2.8. Others
      • 5.4.2.9. Others Market, 2018 to 2030 (USD Million)
    • 5.4.3. Cell Therapy
      • 5.4.3.1. Cell Therapy Market, 2018 to 2030 (USD Million)

Chapter 6. Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type Estimates & Trend Analysis

  • 6.1. Stage of Development by Product Type Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Stage of Development by Product Type Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Non-Clinical
      • 6.4.1.1. Non-Clinical Market, 2018 to 2030 (USD Million)
      • 6.4.1.2. Gene Therapy
      • 6.4.1.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
      • 6.4.1.3. Gene-Modified Cell Therapy
      • 6.4.1.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
      • 6.4.1.4. Cell Therapy
      • 6.4.1.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)
    • 6.4.2. Clinical
      • 6.4.2.1. Clinical Market, 2018 to 2030 (USD Million)
      • 6.4.2.2. Gene Therapy
      • 6.4.2.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
      • 6.4.2.3. Gene-Modified Cell Therapy
      • 6.4.2.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
      • 6.4.2.4. Cell Therapy
      • 6.4.2.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)

Chapter 7. Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Estimates & Trend Analysis

  • 7.1. Stage of Development by Indication Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Stage of Development by Indication Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Oncology
      • 7.4.1.1. Oncology Market 2018 to 2030 (USD Million)
    • 7.4.2. Infectious Diseases
      • 7.4.2.1. Infectious Market 2018 to 2030 (USD Million)
    • 7.4.3. Neurological Disorders
      • 7.4.3.1. Neurological Disorders Market 2018 to 2030 (USD Million)
    • 7.4.4. Rare Diseases
      • 7.4.4.1. Rare Diseases Market 2018 to 2030 (USD Million)
    • 7.4.5. Others
      • 7.4.5.1. Others Market 2018 to 2030 (USD Million)

Chapter 8. Cell & Gene Therapy Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Competitive Scenario
      • 8.6.1.3. Regulatory Framework
      • 8.6.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 8.6.2. Germany
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 8.6.3. France
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 8.6.4. Italy
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 8.6.5. Spain
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 8.6.6. Denmark
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 8.6.7. Sweden
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 8.6.8. Norway
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Framework
      • 8.6.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key Country Dynamics
      • 8.7.1.2. Competitive Scenario
      • 8.7.1.3. Regulatory Framework
      • 8.7.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 8.7.2. India
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 8.7.3. China
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 8.7.4. South Korea
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 8.7.5. Australia
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 8.7.6. Thailand
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key Country Dynamics
      • 8.8.1.2. Competitive Scenario
      • 8.8.1.3. Regulatory Framework
      • 8.8.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 8.8.2. Mexico
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 8.8.3. Argentina
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key Country Dynamics
      • 8.9.1.2. Competitive Scenario
      • 8.9.1.3. Regulatory Framework
      • 8.9.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Competitive Scenario
      • 8.9.2.3. Regulatory Framework
      • 8.9.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 8.9.3. UAE
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Competitive Scenario
      • 8.9.3.3. Regulatory Framework
      • 8.9.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 8.9.4. Kuwait
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Competitive Scenario
      • 8.9.4.3. Regulatory Framework
      • 8.9.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
  • 9.4. Market Participant Categorization
    • 9.4.1. List of key distributors and channel partners
    • 9.4.2. Key customers
    • 9.4.3. Key company market share analysis, 2023
    • 9.4.4. BioAgilytix Labs
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. KCAS Bioanalytical Services
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. IQVIA, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Laboratory Corporation of America Holdings
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Prolytix
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Pharmaron
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Charles River Laboratories
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Service Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Syneos Health
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Service Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. SGS SA
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Service Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Intertek Group Plc
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Service Benchmarking
      • 9.4.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 5 North America Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 6 North America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 7 North America Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 8 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 12 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 16 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 17 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 21 UK Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 UK Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 23 UK Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 24 UK Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 25 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 29 France Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 30 France Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 31 France Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 32 France Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 33 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 36 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 37 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 38 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 39 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 40 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 41 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 42 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 45 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 48 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 49 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 50 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 51 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 52 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 58 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 59 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 60 China Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 61 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 62 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 65 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 66 India Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 67 India Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 68 India Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 69 India Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 70 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 71 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 72 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 73 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 74 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 77 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 78 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 79 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 80 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 81 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 82 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 83 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 84 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 85 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 86 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 87 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 88 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 89 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 90 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 91 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 92 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 93 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 94 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 96 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 98 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 99 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 100 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 101 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 102 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 103 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 104 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 105 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 107 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 112 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 113 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 115 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Market snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook
  • Fig. 17 Related/ancillary market outlook
  • Fig. 18 Cell & gene therapy bioanalytical testing services market - Industry value chain analysis
  • Fig. 19 Cell & gene therapy bioanalytical testing services market driver analysis
  • Fig. 20 Cell & gene therapy bioanalytical testing services market restraint analysis
  • Fig. 21 Cell & gene therapy bioanalytical testing services market: Porter's analysis
  • Fig. 22 Cell & gene therapy bioanalytical testing services market: PESTLE analysis
  • Fig. 23 Cell & gene therapy bioanalytical testing services market: Test type outlook and key takeaways
  • Fig. 24 Cell & gene therapy bioanalytical testing services market: Test type market share analysis, 2023 - 2030
  • Fig. 25 Bioavailability & bioequivalence studies market, 2018 - 2030 (USD Million)
  • Fig. 26 Pharmacokinetics market, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmacodynamics market, 2018 - 2030 (USD Million)
  • Fig. 28 Other test type market, 2018 - 2030 (USD Million)
  • Fig. 29 Cell & gene therapy bioanalytical testing services market: Product type outlook and key takeaways
  • Fig. 30 Cell & gene therapy bioanalytical testing services market: Product type market share analysis, 2023 - 2030
  • Fig. 31 Gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 32 Ex-vivo market, 2018 - 2030 (USD Million)
  • Fig. 33 In-vivo market, 2018 - 2030 (USD Million)
  • Fig. 34 Gene-Modified Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 35 CAR T-Cell Therapies Market, 2018 - 2030 (USD Million)
  • Fig. 36 CAR-NK Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 37 TCR-T Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 38 Other Market, 2018 - 2030 (USD Million)
  • Fig. 39 Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 40 Cell & gene therapy bioanalytical testing services market: stage of development by product type outlook and key takeaways
  • Fig. 41 Cell & gene therapy bioanalytical testing services market: Stage of development by product type market share analysis, 2023 - 2030
  • Fig. 42 Non-clinical market, 2018 - 2030 (USD Million)
  • Fig. 43 Gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 44 Gene-modified cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 45 Cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 46 Clinical market, 2018 - 2030 (USD Million)
  • Fig. 47 Gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 48 Gene-modified cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 49 Cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 50 Cell & gene therapy bioanalytical testing services market: Indication outlook and key takeaways
  • Fig. 51 Cell & gene therapy bioanalytical testing services market: Indication market share analysis, 2023 - 2030
  • Fig. 52 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 53 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 54 Neurological disorders market, 2018 - 2030 (USD Million)
  • Fig. 55 Rare diseases market, 2018 - 2030 (USD Million)
  • Fig. 56 Others market, 2018 - 2030 (USD Million)
  • Fig. 57 Regional marketplace: Key takeaways
  • Fig. 58 Regional marketplace: Key takeaways
  • Fig. 59 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. key country dynamics
  • Fig. 61 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Canada key country dynamics
  • Fig. 63 Canada market, 2018 - 2030 (USD Million)
  • Fig. 64 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Germany key country dynamics
  • Fig. 66 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 UK key country dynamics
  • Fig. 68 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 France key country dynamics
  • Fig. 70 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Italy key country dynamics
  • Fig. 72 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Spain key country dynamics
  • Fig. 74 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Denmark key country dynamics
  • Fig. 76 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Sweden key country dynamics
  • Fig. 78 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Norway key country dynamics
  • Fig. 80 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Japan key country dynamics
  • Fig. 83 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 China key country dynamics
  • Fig. 85 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 India key country dynamics
  • Fig. 87 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Australia key country dynamics
  • Fig. 89 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Thailand key country dynamics
  • Fig. 91 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 South Korea key country dynamics
  • Fig. 93 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Brazil key country dynamics
  • Fig. 96 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Mexico key country dynamics
  • Fig. 98 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Argentina key country dynamics
  • Fig. 100 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 South Africa key country dynamics
  • Fig. 103 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Saudi Arabia key country dynamics
  • Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 UAE key country dynamics
  • Fig. 107 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Kuwait key country dynamics
  • Fig. 109 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 Key company categorization
  • Fig. 111 Company market positioning
  • Fig. 112 Market participant categorization
  • Fig. 113 Strategy framework